76493 Evaluating a Novel, Invisible Sunscreen with MCE Filter and 2-MNG Active for Enhanced Protection Against HEVL-Induced Pigmentation

Ludivine Canchy(Centre Hospitalier de La Rochelle), Thierry Passeron(Inserm), Frédéric Flament(L'Oréal (France)), Pascale Renoux(L'Oréal (France)), Stéphane Douezan(L'Oréal (France)), Françoise Bernerd(L'Oréal (France)), Virginie Piffaut(L'Oréal (France)), Martin Josso(L'Oréal (France)), Jean-Philippe Belaidi(L'Oréal (France)), Marion Mégier(L'Oréal (France)), Claire Marionnet(L'Oréal (France))
Journal of the American Academy of Dermatology
July 1, 2026
10.1016/j.jaad.2026.04.824
Cited by 0

Related Papers

Guidelines for the management of vitiligo: the European Dermatology Forum consensus
|British Journal of Dermatology|2012|446
New insights in photoaging, UVA induced damage and skin types
|Experimental Dermatology|2014|376
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
|The Lancet|2023|318
Clinical and Biological Characterization of Skin Pigmentation Diversity and Its Consequences on UV Impact
|International Journal of Molecular Sciences|2018|294
Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo
|Nature Communications|2019|175